The role of physical activity in the prevention of stroke

Central European Journal of Public Health

Volumn 13, Issue 3, 2005, Pages 132-136

  Chrysohoou, Ch ^a,b,c   Pitsavos, Ch ^a   Kokkinos, P ^b   Panagiotakos, D B ^a   Singh, S N ^b   Stefanadis, Ch ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NONE   (Greece)

Author keywords

Physical activity; Stroke

Indexed keywords

LIPID;

BLOOD CLOTTING; BLOOD VESSEL FUNCTION; CARDIOVASCULAR DISEASE; ENDOTHELIUM; EXERCISE; HUMAN; LIPID BLOOD LEVEL; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; REVIEW; STROKE; THROMBOCYTE AGGREGATION;

CEREBROVASCULAR ACCIDENT; EXERCISE; HUMANS; RISK;

EID: 25444437767     PISSN: 12107778     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Feigin VL: Stroke epidemiology in the developing world. Lancet. 2005;365:2160-1.
2. Quaglini S, Cavallini A, Gerzeli S, Micieli G: Economic benefit from clinical practice guideline compliance in stroke patient management. Health Policy. 2004;69(3):305-15.
3. Goldstein LB, Adams R, Becker K, Furberg CD, Gorelick PB, Hademenos G, Hill M, Howard G, Howard VJ, Jacobs B, Levine SR, Mosca L, Sacco RL, Sherman DG, Wolf PA, del Zoppo GJ: Primary prevention of ischemic stroke: a statement for health care professionals from the Stroke Council of the American Heart Association. Circulation. 2001;103(1):163-82.
4. Matson-Koffman DM, Brownstein JN, Neiner JA, Greaney ML: A site-specific literature review of policy and environmental interventions that promote physical activity and nutrition for cardiovascular health: what works? Am J Health Promot. 2005;19(3):167-93.
5. Pate RR, Pratt M, Blair SN, Haskell WL, Macera CA, Bouchard C, Buchner D, Ettinger W, Heath GW, King AC: Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA. 1995 Feb 1; 273(5):402-7.
6. Cha JK, Jeong MH, Kim JW: Statin reduce the platelet p-selectin expression in atherosclerotic ischemic stroke. J Thromb Thrombolysis. 2004;18(1):39-42.
7. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T: Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005;352(8):777-85.
8. Uchino K, Alexandrov AV, Garami Z, El-Mitwalli A, Morgenstern LB, Grotta JC: Safety and feasibility of a lower dose intravenous TPA therapy for ischemic stroke beyond the first three hours. Cerebrovasc Dis. 2005;19(4):260-6.
9. Lee IM, Hennekens CH, Berger K, Buring JE, Manson JE: Exercise and risk of stroke in male physicians. Stroke. 1999;30(1):1-6.
10. Shephard RJ, Balady GL: Exercise as cardiovascular therapy. Circulation. 1999;99(7):963-72.
11. Wannamethee G, Shaper AG: Physical activity and stroke in British middle aged men. BMJ. 1992;304(6827):597-601.
12. Abbott RD, Rodriguez BL, Burchfiel CM, Curb JD: Physical activity in older middle-aged men and reduced risk of stroke: the Honolulu Heart Program. Am J Epidemiol. 1994;139(9):881-93.
13. Gillum RF, Mussolino ME, Ingram DD: Physical activity and stroke incidence in women and men. The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol. 1996;143(9):860-9.
14. Lee IM, Paffenbarger RS Jr: Physical activity and stroke incidence: the Harvard Alumni Health Study. Stroke. 1998;29(10):2049-54.
15. Nakayama T, Date C, Yokoyama T, Yoshiike N, Yamaguchi M, Tanaka H: A 15.5-year follow-up study of stroke in a Japanese provincial city. The Shibata Study. Stroke. 1997;28(1):45-52.
16. Hu FB, Stampfer MJ, Colditz GA, Ascherio A, Rexrode KM, Willett WC, Manson JE: Physical activity and risk of stroke in women. JAMA. 2000;283(22):2961-7.
17. Manson JE, Greenland P, LaCroix AZ, Stefanick ML, Mouton CP, Oberman A, Perri MG, Sheps DS, Pettinger MB, Siscovick DS: Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med. 2002;347(10):716-25.
18. Ellekjær H, Holmen J, Ellekjær E, Vatten L: Physical activity and stroke mortality in women ten-year follow-up of the Nord-Trøndelag Health Survey, 1984-1986. Stroke. 2000;31(1):14-8.
19. Pitsavos C, Panagiotakos DB, Chrysohoou C, Kokkinos P, Menotti A, Singh S, Dontas A: Physical activity decreases the risk of stroke in middle-age men with left ventricular hypertrophy: 40-year follow-up (1961-2001) of the Seven Countries Study (the Corfu cohort). J Hum Hypertens. 2004;18(7):495-501.
20. Lee CD, Folsom AR, Blair S: Physical activity and stroke risk A meta-analysis. Stroke. 2003;34(10):2475-82.
21. Evenson KR, Rosamond WD, Cai J, Toole JF, Hutchinson RG, Shahar E, Folsom AR: Physical activity and ischemic stroke risk. The atherosclerosis risk in communities study. Stroke. 1999;30(7):1333-9.
22. Harmsen P, Rosengren A, Tsipogianni A, Wilhelmsen L: Risk factors for stroke in middle-aged men in Goteborg, Sweden. Stroke. 1990;21(2):223-39.
23. Elekjaer EF, Wyller TB, Sverre JM, Holmen J: Lifestyle factors and risk of cerebral infarction. Stroke. 1992;23(6):829-34.
24. Fletcher GF: Exercise in the prevention of stroke. Health Rep. 1994;6(1):106-10.
25. Kokkinos PF, Narayan P, Colleran JA, Pittaras A, Notargiacomo A, Reda D, Papademetriou V: Effects of regular exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension. N Engl J Med. 1995;333(22):1462-7.
26. Lakka TA, Salonen JT: Moderate to high intensity conditioning leisure time physical activity and high cardiorespiratory fitness are associated with reduced plasma fibrinogen in eastern Finnish men. J Clin Epidemiol. 1993;46(10):1119-27.
27. Williams PT: High-density lipoprotein cholesterol and other risk factors for coronary heart disease in female runners. N Engl J Med. 1996;334(20):1298- 303.
28. Jacobs IH, Wentworth D: Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the Multiple Risk Factor Intervention Trial. N Engl J Med. 1989;320(14):904-10.
29. Kargman DE, Tuck C, Berglund L, Lin IF, Mukherjee RS, Thompson EV, Jones J, Boden-Albala B, Paik MC, Sacco RL: Lipid and lipoprotein levels remain stable in acute ischemic stroke: the Northern Manhattan Stroke Study. Atherosclerosis. 1998;139(2):391-9.
30. Bucher HC, Griffith LE, Guyatt GH: Systematic review on the risk and benefit of different cholesterol-lowering interventions. Arterioscler Thromb Vasc Biol. 1999;19(2):187-95.
31. Peng DQ, Zhao SP, Wang JL: Lipoprotein (a) and apolipoprotein E epsilon 4 as independent risk factors for ischemic stroke. J Cardiovasc Risk. 1999;6(1):1-6.
32. Rosenson RS, Tangney CC: Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. JAMA. 1998;279(20):1643-50.
33. Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald E: Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation. 1999;100(3):230-5.
34. Grandjean PW, Crouse SF, Rohack JJ: Influence of cholesterol status on blood lipid and lipoprotein enzyme responses to aerobic exercise. J Appl Physiol. 2000;89(7):472-80.
35. Powell K, Thompsen P, Caspersen C, Kendrick J: Physical activity and the incidence of coronary heart disease. Ann Rev Public Health. 1987;8:253-87.
36. Wannamethee SG, Lowe GDO, Whincup PH, Rumley A, Walker M, Lennon L: Physical activity and hemostatic and inflammatory variables in elderly men. Circulation. 2002;105(15):1785-90.
37. Tanaka H, Seals DR, Monahan KD, Clevenger CM, Desouza CA, Dinenno FA: Regular aerobic exercise and the age-related increase in carotid artery intima-media thickness in healthy men. J Appl Physiol. 2002;92(4):1458-64.
38. Green DJ, Walsh JH, Maiorana A, Burke V, Taylor RR, O'Driscoll JG: Comparison of resistance and conduit vessel nitric oxide-mediated vascular function in vivo: effects of exercise training. J Appl Physiol. 2004;97(2):749-55.
39. Lakka TA, Salonen JT: Moderate to high intensity conditioning leisure time physical activity and high cardiorespiratory fitness are associated with reduced plasma fibrinogen in eastern Finnish men. J Clin Epidemiol. 1993;46(10):1119-27.
40. Fukai T, Siegfried MR, Ushio-Fukai M, Cheng Y, Kojda G, Harrison DG: Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. J Clin Invest. 2000;105(11):1631-9.
41. Graham DA, Rush JW: Exercise training improves aortic endothelium-dependent vasorelaxation and determinants of nitric oxide bioavailability in spontaneously hypertensive rats. J Appl Physiol. 2004;96(6):2088-96.
42. Dimmeler S, Zeiher AM: Exercise and cardiovascular health: get active to "AKTivate" your endothelial nitric oxide synthase. Circulation. 2003;107(25):3118-20.
43. Haendeler J, Hoffmann J, Tischler V, Berk BC, Zeiher AM, Dimmeler S: Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69. Nat Cell Biol. 2002;4(10):743-9.
44. Green DJ, Walsh JH, Maiorana A, Best MJ, Taylor RR, O'Driscoll JG: Exercise-induced improvement in endothelial dysfunction is not mediated by changes in CV risk factors: pooled analysis of diverse patient populations. Am J Physiol Heart Circ Physiol. 2003;285(6):H2679-87.
45. Koenig W, Sund M, Doring A, Ernst E: Leisure-time physical activity but not work-related physical activity is associated with decreased plasma viscosity. Circulation. 1997;95(2):335-41.
46. Montgomery HE, Clarkson P, Nwose OM, Mikailidis DP, Jagroop IA, Dollery C, Moult J, Benhizia F, Deanfield J, Jubb M, World M, McEwan JR, Winder A, Humphries S: The acute rise in plasma fibrinogen concentration with exercise is influenced by the G-453-A polymorphism of the β-fibrinogen gene. Arter Thromb Vasc Biol. 1996;16(3):386-91.
47. Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, Franklin BA, Goldstein LB, Greenland P, Grundy SM, Hong Y, Miller NH, Lauer RM, Ockene IS, Sacco RL, Sallis JF Jr, Smith SC Jr, Stone NJ, Taubert KA: AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. Circulation. 2002;106(3):388-91.
48. Hack W, Kaste M, Bogousslavsky J, Brainin M, Chamorro A, Lees K, Leys D, Kwiecinski H, Toni P, Langhorne P, Diener C, Hennerici M, Ferro J, Sivenius J, Gunnar N, Bath P, Olsen TS, Gugging M: European Stroke Initiative Recommendations for Stroke Management - update 2003. Cerebrovasc Dis. 2003;16(4):311-37.
49. Kokkinos PF, Narayan P, Fletcher RD, Tsagadopoulos D, Papademetriou V: Effects of aerobic training on exaggerated blood pressure response to exercise in African-Americans with severe systemic hypertension treated with indapamide-verapamil-enalapril. Am J Cardiol. 1997;79(10):1424-6.
50. Wachtell K, Lehto M, Gerdts E, Olsen MH, Hornestam B, Dahlof B, Ibsen H, Julius S, Kjeldsen SE, Lindholm LH, Nieminen MS, Devereux RB: Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) Study. J Am Coll Cardiol. 2005;45(5):712-9.
51. Pahor M, Psaty B, Alderman M, Applegate W, Williamson J, Cavazzini C, Furberg C: Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials. Lancet. 2000;356(9246):1949-54.
52. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342(3):145-53.
53. Lock K, Pomerleau J, Causer L, Altmann DR, McKee M: The global burden of disease attributable to low consumption of fruit and vegetables: implications for the global strategy on diet. Bull World Health Organ. 2005 Feb; 83(2):100-8.